" University of Utah Hospital is an established leader in stroke care and we are pleased to be collaborating with Dr. Stevens and his team," said David Graves, IMRIS Chairman & CEO. "We believe IMRISNV will make an important contribution to improving outcomes for stroke patients and the addition of study data from University of Utah's Clinical Neurosciences Center will further demonstrate the capabilities of IMRISNV."Today's announcement marks the second IMRIS system for University of Utah Health Care. In late 2009, Huntsman Cancer Hospital selected an IMRISneuro system. In the last ten years, Huntsman Cancer Institute has grown to become one of America's major cancer research centers.
University Of Utah Hospital Purchases IMRISNV
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.